Comparison of bicalutamide 150 mg coupled with the standard therapy and only standard methods of treatment in early prostate cancer

by D. G. McLeod, P. Iversen, W. A. See, T. Morris, J. Armstrong, M. P. Wirth
Published 2020-02-01